RE:RE:"impressive, paradigm shifting, photodynamic therapy"Well Slayer , We've been looking at this for many years now as a pivitol Phase 2. So Maybe Dr. Uddin is thinking a phase 3 will have to happen? I doubt it will take TLT another 3 years to treat ~50-60 more patients at 20 sites? I do think the criteria is still 20-25 CR data to apply for AA and that can happen with merely a FTD. BTD would just speed the process up. Perhaps Dr. Uddin isn't aware? Anyway FDA has a certain amount of time to respond to any application by TLT. I see no reason why the current data, once tallied, wouldn't suffice towards this BTD/AA application.
Slayer, I hope Dr. Uddin is just over looking something here. Or maybe you are correct about the ~100/125 patients being the new norm. I still think that would mean we get AA next year. Not 2026.